Chunying Jiang

Chunying Jiang

Auto-generated profile, based on publicly available information

Chunying Jiang

Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 201318, P. R. China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
BZBochuan Zhang
Bochuan Zhang
QWQingfeng Wang
Qingfeng Wang
CFChenghao Fu
Chenghao Fu
CJChunying Jiang
Chunying Jiang
MSMa Shiliang
Ma Shiliang
Background: In this study, we aimed to explore the tumour associated immune signature of breast cancer (BC) and conduct integrative analyses with immune infiltrates in BC. Methods: We downloaded the transcriptome profiling and clinical data of BC from The Cancer Genome Atlas (TCGA) database. The list of immune-related signatures was from the Innate database. The limma package was utilized to conduct the normalization, and we screened the differential immune signatures in BC. A univariate Cox regression model and the LASSO method were used to find the hub prognostic immune genes. The TAIG risk model was calculated based on the multivariate Cox regression results, and a receiver operating characteristic (ROC) curve was generated to assess the predictive power of TAIG. Moreover, we also conducted a correlation analysis between TAIG and the clinical characteristics. Additionally, we utilized the METABRIC cohort as the validation data set. The TIMER database is a comprehensive resource for performing systematic analyses of immune infiltrates across various malignancies. We evaluated the associations of immune signatures with several immune cells based on TIMER. Furthermore, we used the CIBERSORT algorithm to determine the fractions of immune cells in each sample and compared the differential distributions of immune infiltrates between two TAIG groups using the Wilcoxon rank-sum test. Results: A total of 1,178 samples were obtained from the TCGA-BRCA database, but only 1,045 breast tumour samples were matched with complete transcriptome expression data. Meanwhile, we collected a total of 1,094 BC patients from the METABRIC cohort. We found a list of 1,399 differential immune signatures associated with survival, and functional analysis revealed that these genes participated in cytokine-cytokine receptor interactions, Th1 and Th2 cell differentiation and the JAK-STAT signalling pathway. The TAIG risk model was established from the multivariate Cox analysis, and we observed that high TAIG levels correlated with poor survival outcomes based on Kaplan-Meier analysis. The Kruskal-Wallis test suggested that high TAIG levels correlated with high AJCC-TNM stages and advanced pathological stages (P<0.01). We validated the well robustness of TAIG in METABRIC cohort and 5-year AUC reached up to 0.829. Moreover, we further uncovered the associations of hub immune signatures with immune cells and calculated the immune cell fractions in specific tumour samples based on gene signature expression. Last, we used the Wilcoxon rank-sum test to compare the differential immune density in the two groups and found that several immune cells had a significantly lower infiltrating density in the high TAIG groups, including CD8+ T cells (P=0.031), memory resting CD4+ T cells (P=0.026), M0 macrophages (P=0.023), and M2 macrophages (P=0.048). Conclusions: In summary, we explored the immune signature of BC and constructed a TAIG risk model to predict prognosis. Moreover, we integrated the identified immune signature with tumour-infiltrating immune cells and found adverse associations between the TAIG levels and immune cell infiltrating density.

30 July 2024 in Cryobiology
Verified
Journal Article
Closed access
MAMaimaiti Aimaitijiang
Maimaiti Aimaitijiang
AGAisikaer Gulisitan
Aisikaer Gulisitan
ZZZhengyan Zhai
Zhengyan Zhai
AAAili Atawula
Aili Atawula
CJChunying Jiang
Chunying Jiang

1 December 2021 in Cryobiology
Verified
Journal Article
Open access
CJChunying Jiang
Chunying Jiang
JZJun Zhang
Jun Zhang
ZRZhongyuan Ren
Zhongyuan Ren
RGRong Guo
Rong Guo
HLHailing Li
Hailing Li
YXYawei Xu
Yawei Xu
A significant proportion of patients with recurrent atrial fibrillation (AF) require repeat radiofrequency (RF) ablation after cryoballoon (CB) ablation. However, little is known about the pulmonary vein (PV) potential reconnection to left atrium and localization of gaps in the initial lesion sets following cryoablation in patients with recurrent AF. The data of 29 consecutive patients with repeat RF ablation for recurrent AF were analyzed. During the second ablation procedures, PV foci of AF were explored in 116 PVs by the CARTO system. All patients had complete PV isolation from initial cryoablation procedure. The fluoroscopy duration, mean cryoablation time and mean cryoablation frequency were lowest for the right superior pulmonary vein (RSPV) (58.69 +/- 9.18 s, 185.10 +/- 49.25 s and 1.07 +/- 0.26; p = 0.024, p = 0.042 and p = 0.032). A significantly higher incidence of conduction gaps per patient was found for the RSPVs compared to the other PVs (p < 0.05 or p < 0.01). For RSPVs, it seemed that gaps were predominantly located at the anterior segment (22 gaps) and inferior segment (22 gaps). RSPV reconnection was independently related to a lower risk of major adverse events after the second ablation during follow up in the study patients (HR 0.275, 95%CI 0.078-0.967, p = 0.044). AF recurrence in patients after cryoablation is significantly associated with conduction gaps in the anterior and inferior segments of RSPVs. Various ablation strategies of close touch of CB on anterior and inferior segments of RSPV ostium, more freezing time and frequency for RSPV may help achieving durable PV isolation during follow

22 October 2025 in Journal of Mechanics in Medicine and Biology
Verified
Journal Article
Closed access
JYJiyu Yang
Jiyu Yang
RWRui Wang
Rui Wang
LDLingzhi Dou
Lingzhi Dou
AAAili Atawula
Aili Atawula
CYChengying Yan
Chengying Yan
CJChunying Jiang
Chunying Jiang

30 January 2024
Verified
Preprint
Open access
CJChunying Jiang
Chunying Jiang
DZDongdong Zhao
Dongdong Zhao
KTKai Tang
Kai Tang
YWYiqian Wang
Yiqian Wang
XLXiang Li
Xiang Li
BHBing Han
Bing Han
Background: Paroxysmal atrial fibrillation (AF) is closely related to pathophysiologic processes and clinical outcomes. However, it is uncertain whether cryoablation of pulmonary veins isolation is effective and safe for patients of symptomatic and drug-refractory AF type within 24-hour episode duration. Methods: The patients were designed into Group A (253 patients of paroxysmal AF within 24-hour episode duration) and Group B (253 patients of paroxysmal AF lasted for 24 hours or longer) on a 1:1 basis by identical propensity scores. Mortality, stroke/transient ischemic attack (TIA) and complications relevant to the cryoablation procedure were compared and recurrence of atrial tachyarrhythmia was analyzed for clinical independent predictors. Results: The rate of atrial tachyarrhythmia recurrence was 21.74% in Group A and 30.04% in Group B, respectively (P=0.042). At 12-month follow-up from procedure, lower incidences of stroke/TIA endpoint of the patients were observed in Group A compared with Group B by Kaplan–Meier analysis [HR 0.34 (0.13–0.87), P= 0.025]. No significant differences about mortality and complications relevant to the cryoablation procedure were observed between Group A and Group B. Moreover, adjusted multivariable Cox regression analysis showed that < 24-hour paroxysmal AF type (HR 0.644, 95% CI: 0.455–0.913, P=0.014) and left atrium diameter (>40 mm) (HR 1.696, 95% CI: 1.046–2.750, P=0.032) were independently associated with the incidence of recurrence of atrial tachyarrhythmia in the study. Conclusions: Cryoablation of AF within 24-hour episode duration is effective and safe for patients with paroxysmal AF.

11 August 2025 in Journal of Mechanics in Medicine and Biology
Verified
Journal Article
Closed access
JYJiyu Yang
Jiyu Yang
ZLZongjin Li
Zongjin Li
CJChunying Jiang
Chunying Jiang
QLQijuan Li
Qijuan Li
CYChengying Yan
Chengying Yan
YLYe Lin
Ye Lin